Cause and Effect Diagram: Also known as the Ishikawa or fishbone diagram, this tool helps you analyze the root causes contributing to an outcome.Each of the ten tools can be used with the Model for Improvement, Lean, or Six Sigma, and includes a short description, instructions, an example, and a blank template. “In fact, the pilot program allowed us to expand talent and resources that improved our productivity and service offerings everywhere.IHI’s QI Essentials Toolkit includes the tools and templates you need to launch a successful quality improvement project and manage performance improvement. “MediQuant is focused 100% on helping all healthcare organizations – whether it’s for the DHA, large health systems, critical care access hospitals or physician practice groups – to safely and securely transition systems and preserve longitudinal views of patient records through archiving legacy data,” said Dave Lamar, Chief Growth Officer.
MediQuant connects patients at the point of care, which dramatically improves the depth of information clinicians have to care for patients. MediQuant cleans and matches data before either migrating multiple retired electronic medical records (EMRs) to its DataArk® system, linking historical patient records to the active EHR, or converting legacy data in retired EMRs to a health system’s enterprise MPI.
Since the beginning of the DHA pilot project, MediQuant increased its staff by 40%, building a dedicated team for government and reinforcing resources for commercial businesses. ECS/MediQuant won the bid to serve as the only legacy archiving vendor from among 80 competitors across healthcare data archivers, major technology and SaaS companies, and large defense contractors. The system includes joint medical services to the Army, Navy and Air Force with 9.5 million beneficiaries, 150,000 staff members, 1,300 locations worldwide and 723 Military Treatment Facilities.
MediQuant’s DataArk archiving system was selected after four years of bidding and testing and a successful six-month pilot.
0 kommentar(er)
